UCSD Faculty Contextualize Cases of Cutaneous Squamous Cell Carcinoma

Podcast

In Partnership With:

Drs Park, Daniels, Sanghvi, and Kolb, discuss two high-risk non-melanoma skin cancer cases and highlighted patient and tumor risk factors to consider in the clinical setting.

Welcome to OncLive On AirTM! I’m your host today, Jessica Hergert.

OncLive On AirTM is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we had the pleasure of speaking with Soo Park, MD, a medical oncologist and assistant professor of medicine, Gregory Daniels, MD, PhD, a medical oncologist and professor of medicine, Parag Sanghvi, MD, MSPH, a radiation oncologist, vice chair, and associate professor of radiation, and Frederic Kolb, MD, MS, MRes, a plastic surgeon and professor of surgery, all at the University of California, San Diego Health, to discuss the appropriate use of immunotherapy plus radiation therapy in patients with aggressive cutaneous squamous cell carcinoma and the role of surgery in patients with cutaneous squamous cell carcinoma and perineural invasion.

In our exclusive interview, Drs Park, Daniels, Sanghvi, and Kolb, discussed two high-risk non-melanoma skin cancer cases and highlighted patient and tumor risk factors to consider in the clinical setting.

Related Videos
Daniel Olson, MD
Neil D. Gross, MD, FACS
Neil D. Gross, MD, FACS
William B. Pearse, MD
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center
Michael Choi, MD, UCSD Health